New York, NY, United States of America

Celia Andreu-Agullo


 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Celia Andreu-Agullo: Pioneering Cancer Treatment Solutions

Introduction

Celia Andreu-Agullo is a distinguished inventor based in New York, NY, known for her significant contributions to the field of cancer research. With a focus on developing high-affinity anti-MERTK antibodies, her work represents a meaningful advancement in therapeutic approaches for cancer treatment.

Latest Patents

Celia holds two patents, with her latest focusing on "High-affinity anti-MERTK antibodies and uses thereof." This patent discloses antibodies that specifically bind to Mer Tyrosine Kinase (MERTK), notably human MERTK. It further describes innovative compositions that include these antibodies as well as antibody-drug conjugates. These conjugates consist of an anti-MERTK antibody linked to cytotoxic agents, enhancing targeted treatment strategies for patients in need. The patent additionally outlines methods for treating cancer through the administration of these specialized antibodies and conjugates.

Career Highlights

Celia currently works at Inspirna, Inc., a company dedicated to advancing cancer therapies and improving patient outcomes. Her role involves pushing the boundaries of research and development in antibody technology, emphasizing the importance of targeted cancer treatments.

Collaborations

Throughout her career, Celia has collaborated with esteemed colleagues, including Masoud Tavazoie and Isabel Kurth. These partnerships have fostered a rich environment of innovation and collective expertise, contributing to the development of cutting-edge solutions in the field of oncology.

Conclusion

Celia Andreu-Agullo continues to be a leading figure in cancer research and antibody development. Her inventions not only showcase her dedication as an inventor but also highlight the potential for innovative therapies to make a lasting impact on cancer treatment. The work being conducted at Inspirna, Inc., alongside her talented collaborators, promises a brighter future for patients battling cancer.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…